- Breast cancer
- Inflammatory breast cancer
- Invasive breast cancer
- Invasive ductal carcinoma
- Invasive lobular carcinoma
- Local tumor recurrence
- Male breast cancer
- Triple negative breast cancer
- Triple positive breast cancer
Ritu Parna Chakrabarti, MD
About me
- Assistant Professor of Clinical Medicine (Hematology-Oncology)
My education and training
- Saint George's University School of MedicineMedical School
- Jersey City Medical Center, Rutgers HealthResidency
- Jersey Shore Medical CenterFellowship
Spoken languages
Insurance accepted
- Aetna Advantra Cares D-SNP
- Aetna Advantra Credit Value
- Aetna Advantra Eagle HMO
- Aetna Advantra Eagle POS
- Aetna Advantra Premier Plus PPO
- Aetna Advantra Value
- Aetna Advantra Value Plus
- Aetna APCN Plus (Multi-Tier)
- Aetna Better Health Kids (CHIP) - DH Only
- Aetna Flexible Five
- Aetna Freedom Core
- Aetna Gold
- Aetna HMO
- Aetna Philly Prime
- Aetna POS
- Aetna PPO APCN
- Aetna Premier
- Aetna Premier Plus
- Aetna Savings Plus
- Aetna Signature Administrators
- Aetna Student Health Plan PPO
- Aetna Upfront Advantage
- First Health HMO
- First Health POS
- First Health PPO
- Meritain - Aramark (Other)
- Meritain - Aramark (Pennsylvania Premier Medical Plan)
- Americhealth Caritas of PA VIP - LGH Only
- Amerihealth Caritas (Transplant patients only)
- Amerihealth Caritas of PA - LGH Only
- Centivo EPO
- Cigna Healthcare EPO
- Cigna Healthcare HMO
- Cigna Healthcare POS
- Cigna Healthcare PPO
- Claim Watcher (Homestead/ INDECs) Open Access
- Clover Health Choice
- Clover Health Choice Value PPO
- Clover Health Classic HMO
- Clover Health Value
Locations
Penn Medicine hospital privileges
- Hospital of the University of Pennsylvania: Has privileges to treat patients in the hospital.
Qualifications and experience
- Internal Medicine, 2022
- Medical Oncology, 2025
- American Society of Clinical Oncology, International
- Breast cancer care
All conditions and treatments
Research
Publications
Jacob S, Li F, Sacksith K, Lee K, Chakrabarti R, Jankowitz R, Taranto E, Knollman H, Makhlin I, Clark AS, Shash PD, DeMichele A, Apostolidis S Changes in Patient Reported Outcomes Associated with Immune-related Toxicity: Interim Analysis from a Prospective Cohort of Locally Advanced TNBC Receiving Neoadjuvant Chemoimmunotherapy , 2026 San Antonio Breast Cancer Symposium: 2026
Jacob S, Li F, Sacksith K, Lee K, Chakrabarti R, Jankowitz R, Taranto E, Knollman H, Makhlin I, Clark AS, Shash PD, DeMichele A, Apostolidis S Early Peripheral CD8+ T-Cell Dynamics Associated With Immune-Related Toxicity: Interim Analysis From a Prospective Cohort of Locally Advanced TNBC Receiving Neoadjuvant Chemo-immunotherapy , 2026 San Antonio Breast Cancer Symposium: 2026
Chakrabarti R, Siegel D, Biran N. The Evolving Role of Checkpoint Inhibitors in Multiple Myeloma , Clin Lymphoma Myeloma Leuk: 2025
Chakrabarti, R., DeRosairo A, Peters S, Patel D, Tariq F, Abdulaaima M, Desai A, Jain D, Shanbhogue, D. Incidence of AKI and Clinical Outcomes in Patients Hospitalized with COVID-19 , J Gen Intern Med.: 2021
Chakrabarti R, Abdulaaima M, Gaiazov S, Shah A, Tharakan J, Tharakan K, Patel A. A look at the Immune Response to COVID-19 in Cancer Patients: Incidence of SARS-CoV2 IgG Antibodies Among Cancer Patients in a Hematology-oncology Clinic. , Oncolytics Today: 2021
Heaton J, Okoh AK, Sossou C, Singh S, Sandhu M, Chakrabarti R, Rao R, Waxman S, Tayal R, Wasty N. Adverse Events After Left Atrial Appendage Closure: Lessons Learned From the Manufacturer and User Facility Device Experience (MAUDE) Database , J Invasive Cardiol: 2020